Shri Kartikeya Pharma
Kartikeya Baldwa is the C.E.O at Ixoreal Biomed, the maker of KSM-66, the highest concentration full-spectrum root extract of ashwagandha available today. Ixoreal is part of the "Baldwa Group", a consortium of companies diversified into logistics, chemicals, power, textiles, real-estate, agriculture and jewelry, with $350 million in annual revenue. Mr.Baldwa spearheaded the development of KSM-66, all the way from assembling the initial team of scientists, to the acquisition of farms and capital infrastructure and to market launch and product validation by regulatory bodies. KSM-66 Ashwagandha is the best-selling ashwagandha on the world market today and appears in more than 600 finished products of major dietary supplement companies across the globe. It has brought Ayurveda to a wider global recognition. Mr.Baldwa has made ashwagandha widely visible and has it beyond capsules and tablets into foods and beverages and other delivery mechanisms. He worked in the Information Technology practice for a year at Deloitte Consulting before starting Ixoreal. Mr.Baldwa studied chemical engineering at Osmania University in India and then business management at the Graduate School of Business at Stanford University in California. He has also attended advanced management programs at Indian School of Business in Hyderabad and Anderson Business School in Los Angeles. He has delivered several guest lectures and is the recipient of "Young Entrepreneur Award 2015" by iCOVE.
Esca Bona at SupplySide West: Supply Hero Highlights: REBBL & Ixoreal